Ngā hua rapu kaituhi :: APM

1

Acute changes to biomarkers as a consequence of prolonged strenuous running mā Stephen R. Bird, Matthew D. Linden, John A. Hawley

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization mā Mark I. Furman, Lori A. Krueger, Matthew D. Linden, Marc R. Barnard, Andrew L. Frelinger, Alan D. Michelson

I whakaputaina 2004

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Aspirin ‘resistance’: role of pre‐existent platelet reactivity and correlation between tests mā Andrew L. Frelinger, Y. LI, Matthew D. Linden, Inge Tarnow, M.R. BARNARD, Marsha L. Fox, Alan D. Michelson

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Residual Arachidonic Acid–Induced Platelet Activation via an Adenosine Diphosphate–Dependent but Cyclooxygenase-1– and Cyclooxygenase-2–Independent Pathway mā Andrew L. Frelinger, Mark I. Furman, Matthew D. Linden, Youfu Li, Marsha L. Fox, Marc R. Barnard, Alan D. Michelson

I whakaputaina 2006

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Effects of platelet binding on whole blood flow cytometry assays of monocyte and neutrophil procoagulant activity mā M.R. BARNARD, Matthew D. Linden, Andrew L. Frelinger, Y. LI, Marsha L. Fox, M.I. Furman, Alan D. Michelson

I whakaputaina 2005

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Indices of platelet activation and the stability of coronary artery disease mā Matthew D. Linden, M.I. Furman, Andrew L. Frelinger, Marsha L. Fox, M.R. BARNARD, Y. LI, Karin Przyklenk, Alan D. Michelson

I whakaputaina 2007

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosis mā Karin Przyklenk, Andrew L. Frelinger, Matthew D. Linden, Peter Whittaker, Y. LI, M.R. BARNARD, John Adams, Michael Morgan, Hussien Al‐Shamma, Alan D. Michelson

I whakaputaina 2009

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia mā Bethan Psaila, James B. Bussel, Andrew L. Frelinger, Bracken Babula, Matthew D. Linden, Y. LI, M.R. BARNARD, Christian Tate, Eric J. Feldman, Alan D. Michelson

I whakaputaina 2011

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation mā Bethan Psaila, James B. Bussel, Matthew D. Linden, Bracken Babula, Youfu Li, Marc R. Barnard, Chinara M. Tate, Kanika Mathur, Andrew L. Frelinger, Alan D. Michelson

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Platelet activation in cystic fibrosis mā Brian O’Sullivan, Matthew D. Linden, Andrew L. Frelinger, Marc R. Barnard, Michele Spencer‐Manzon, James E. Morris, Raneem O. Salem, Michael Laposata, Alan D. Michelson

I whakaputaina 2005

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Evidence that pre‐existent variability in platelet response to ADP accounts for ‘clopidogrel resistance’ mā Alan D. Michelson, Matthew D. Linden, M.I. Furman, Yun Li, M.R. BARNARD, Marsha L. Fox, Wei C. Lau, Thomas J. McLaughlin, Andrew L. Frelinger

I whakaputaina 2006

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: